Funding for this research was provided by:
European Union FP7 (306090)
Received: 28 February 2019
Accepted: 20 June 2019
First Online: 19 July 2019
Ethics approval and consent to participate
: Ethical clearance was obtained from the Research Ethics Committee at KIT for the generic protocol, and each country obtained ethical clearance from the local ethics committees – Bangladesh: Ethical Review Committee, James P. Grant School of Public Health, BRAC University approval 26 August 2013; Ethiopia: SNNP Regional State Health Bureau ethical approval of 18/10/05 (2005 Ethiopian calendar; 2013 Gregorian calendar); Indonesia: Eijkman Institute Research Ethics Commission approval of 31 July 2013; Kenya: KEMRI Ethics Review Committee approval of 16 August 2013 (KEMRI/RES/7/3/1); Malawi: National Health Sciences Research Committee, approval NHSRC #1168 of 6 June 2013; Mozambique: Scientific Council of the Eduardo Mondlane University ethical approval of 3 June 2013. Written informed consent to participate in the study was sought from all interview and focus group participants, in each of the six countries.
: Not applicable.
: The authors declare that they have no competing interests.